A research trial led by Danish researchers has received approval to proceed in Guinea-Bissau, where the recommended dose of the hepatitis B vaccine will be withheld from thousands of newborns. The trial forms a central part of the vaccine vision promoted by Robert F Kennedy Jr, the US Department of Health and Human Services secretary and a known vaccine opponent.

Key facts

  • A research trial received approval to move forward in Guinea-Bissau.
  • The trial will withhold the recommended dose of the hepatitis B vaccine from thousands of newborns.
  • The study is being conducted by Danish researchers.
  • The trial is a central part of the vaccine vision of Robert F Kennedy Jr, US Department of Health and Human Services secretary and vaccine opponent.

The Guardian

Source: The Guardian — World — Read original story